Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Blood Advances
|
April 16, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, et al.
Transplantation and Cellular Therapy
|
August 31, 2022
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
Paul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial
Lauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 6, 2010
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies
Eneida R Nemecek, Katherine A Guthrie, Mohamed L Sorror, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2011
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission
Eneida R Nemecek, Kristin Ellis, Wensheng He, et al.
Bone Marrow Transplantation
|
March 28, 2018
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation
Christine N Duncan, Ruta Brazauskas, Jiaxing Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2015
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
C S Fuchs, S Azevedo, T Okusaka, et al.
Haematologica
|
June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801
Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia
Parinda A Mehta, Mei-Jie Zhang, Mary Eapen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Blood Advances
|
April 16, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, et al.
Transplantation and Cellular Therapy
|
August 31, 2022
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
Paul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial
Lauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 6, 2010
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies
Eneida R Nemecek, Katherine A Guthrie, Mohamed L Sorror, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2011
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission
Eneida R Nemecek, Kristin Ellis, Wensheng He, et al.
Bone Marrow Transplantation
|
March 28, 2018
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation
Christine N Duncan, Ruta Brazauskas, Jiaxing Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2015
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
C S Fuchs, S Azevedo, T Okusaka, et al.
Haematologica
|
June 30, 2018
A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801
Paul A Carpenter, Brent R Logan, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia
Parinda A Mehta, Mei-Jie Zhang, Mary Eapen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Page
of 7